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Physiological characterization 
of secondary metabolite producing Penicillium 
cell factories
Sietske Grijseels1 , Jens Christian Nielsen2, Jens Nielsen2,3, Thomas Ostenfeld Larsen1, Jens Christian Frisvad1, 
Kristian Fog Nielsen1, Rasmus John Normand Frandsen1* and Mhairi Workman1
Abstract 
Background: Penicillium species are important producers of bioactive secondary metabolites. However, the 
immense diversity of the fungal kingdom is only scarcely represented in industrial bioprocesses and the upscaling of 
compound production remains a costly and labor intensive challenge. In order to facilitate the development of novel 
secondary metabolite producing processes, two routes are typically explored: optimization of the native producer or 
transferring the enzymatic pathway into a heterologous host. Recent genome sequencing of ten Penicillium species 
showed the vast amount of secondary metabolite gene clusters present in their genomes, and makes them acces-
sible for rational strain improvement. In this study, we aimed to characterize the potential of these ten Penicillium 
species as native producing cell factories by testing their growth performance and secondary metabolite production 
in submerged cultivations.
Results: Cultivation of the fungal species in controlled submerged bioreactors showed that the ten wild type Penicil-
lium species had promising, highly reproducible growth characteristics in two different media. Analysis of the second-
ary metabolite production using liquid chromatography coupled with high resolution mass spectrometry proved that 
the species produced a broad range of secondary metabolites, at different stages of the fermentations. Metabolite 
profiling for identification of the known compounds resulted in identification of 34 metabolites; which included 
several with bioactive properties such as antibacterial, antifungal and anti-cancer activities. Additionally, several novel 
species–metabolite relationships were found.
Conclusions: This study demonstrates that the fermentation characteristics and the highly reproducible perfor-
mance in bioreactors of ten recently genome sequenced Penicillium species should be considered as very encour-
aging for the application of native hosts for production via submerged fermentation. The results are particularly 
promising for the potential development of the ten analysed Penicillium species for production of novel bioactive 
compounds via submerged fermentations.
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Background
Filamentous fungi are important producers of second-
ary metabolites: low-molecular-weight compounds that 
often have bioactive properties. The genus Penicillium 
currently includes more than 354 accepted species [1] 
many of which are capable of producing a wide vari-
ety of secondary metabolites [2]. The most well-known 
secondary metabolite produced by Penicillium is the 
antibiotic penicillin, which was discovered by Flem-
ing [3] and which is nowadays produced in large scale 
using P. rubens, following intense strain improvement 
programs aimed at increasing the titers. Other impor-
tant pharmaceutical compounds produced by Penicil-
lium species include the antifungal griseofulvin [4], the 
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immunosuppressant mycophenolic acid [5] and the 
cholesterol lowering drug compactin/mevastatin [6–8]. 
These examples illustrate the great importance of Peni-
cillium species as production hosts and sources of bioac-
tive compounds with medical applications. On the other 
hand, Penicillium species can also produce mycotoxins 
such as citrinin, ochratoxin and patulin [2], which can 
pose a health risk to humans and animals.
The increasing prevalence of antibiotic resistance 
among pathogenic bacteria was in 2016 named by the 
UN General Assembly to be amongst the greatest and 
most urgent global risk factor for the health of humans 
[9]. However, the discovery of novel antibiotics has stag-
nated since the 1970’s and only few novel classes of anti-
biotics have been discovered since then [10, 11]. This is 
most likely a consequence of the fact that drug develop-
ment is time consuming and expensive, while market 
value and dominance for antibiotics is limited by the 
development of resistance. The broad metabolic diversity 
found within the fungal kingdom, however, continues to 
provide a rich source of novel drug leads, this coupled 
with advancements within process engineering and phys-
iological characterization tools, provides a strong basis 
for exploiting the chemical and physiological diversity in 
fungi to establish novel fungal based bioprocesses which 
can meet the demands of modern society for novel anti-
microbials and pharmaceuticals.
To facilitate the process from identification of a ben-
eficial compound to the establishment of an industri-
ally feasible bio-based production process, two major 
strategies can be followed; i.e. find and optimizing the 
best native producer or transfer the involved genes to an 
established heterologous host. The latter strategy is typi-
cally desirable if the native producer is not suitable for 
industrial fermentation processes or is genetically inac-
cessible. However, production of secondary metabolites 
in heterologous hosts is still in the developmental stage 
and expressing complex multistep pathways to commer-
cially viable titers has proven highly challenging and typi-
cally requires substantial optimization [12]. The transfer 
of the given genetic trait in addition requires a thorough 
understanding of the given biosynthetic pathway and 
the involved genes. The other strategy, advancement 
of the native organism for the production of second-
ary metabolites, can be favourable as this eliminates the 
often tedious work of moving the biosynthetic pathway 
to a heterologous host. However, taming a uncharacter-
ized filamentous fungus for industrial scale production 
is not trivial, as natural secondary metabolite yields are 
often low which combined with the complex interplay 
between physiology, physical environment and morphol-
ogy often causes problems during fermentation such as 
nonhomogeneous mixing and nutrient limitation [13]. 
Therefore, in many instances, relatively unexploited fungi 
are not tested in submerged bioreactor cultivations, even 
though this would provide the necessary process perfor-
mance data to evaluate whether to optimize the native 
producing organism or to transfer the pathway into a het-
erologous host.
The recent genome sequencing of ten Penicillium spe-
cies [14, 15] has provided valuable novel insight into the 
rich diversity in secondary metabolite gene clusters pre-
sent in these Penicillium species and has in addition, 
made the species amenable to rational strain improve-
ment. In this study, we analyzed the potential of these ten 
recently genome sequenced Penicillium species as native 
producing cell factories. The species were cultivated in 
highly controlled bioreactors both in a defined medium 
that allowed for quantitative physiological evaluation and 
in a secondary metabolite inducing complex medium, to 
evaluate overall process performance, growth rates and 
reproducibility. Additionally, secondary metabolite pro-
files of the species during different time points in the fer-
mentation were studied. To our knowledge, none of these 
species had been tested in a bioreactor before. This work 
demonstrates an implementation strategy for novel fun-
gal cell factories based on highly controlled submerged 
bioreactors cultivations and quantification of key physi-
ological parameters.
Methods
Organisms
The species used in this study were P. coprophilum 
(IBT31321), P. nalgiovense (IBT 13039), P. polonicum 
(IBT 4502), P. antarcticum (IBT31811), P. vulpinum (IBT 
29486), P. arizonense (IBT 12289), P. solitum (IBT 29525), 
P. decumbens (IBT11843), P. flavigenum (IBT 14082), and 
P. steckii (IBT 24891). All strains are available from the 
IBT culture collection (Department of Biotechnology and 
Biomedicine, Technical University of Denmark).
Submerged bioreactor batch cultivations
With the aim of investigating the growth characteristics 
of ten potential secondary metabolite producing Peni-
cillium species, submerged bioreactor cultivations were 
performed with each species in two different media in 
biological triplicates.
Media
Czapek yeast autolysate (CYA) medium was used for 
spore propagation, containing per liter of demineral-
ized water: 30  g sucrose, 5  g yeast extract, 3  g  NaNO3, 
1  g  K2HPO4, 0.5  g  MgSO4·7H2O, 0.5  g KCl, 0.01  g 
 FeSO4·7H2O, 20  g agar and 1  mL trace metal solu-
tion containing 0.1  g/L  ZnSO4·7H2O and 0.05  g/L 
 CuSO4·5H2O. The pH was adjusted to 6.2 with NaOH 
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prior to autoclaving. All chemicals applied were obtained 
from Sigma-Aldrich (Sigma-Aldrich).
Batch cultivations were performed in CY medium 
(CM) and in a defined medium (DM) for Penicillium. 
The defined medium contained per liter of demineralized 
water: 15 g glucose, 3.5 g  (NH4)2SO4, 0.5 g  MgSO4·7H2O, 
0.15  g  Na2-EDTA, 0.04  g  FeSO4·7H2O, 0.8  g  KH2PO4, 
5 mL trace solution containing 1 g/L  CuSO4·5H2O, 4 g/L 
 ZnSO4·7H2O, 4 g/L  MnSO4·7H2O, 1 g/L  CaCl2·H2O. The 
CY medium contained the same components as stated 
above for spore propagation without the agar and 15  g 
sucrose per liter. The medium was heat sterilized by auto-
claving at 121 °C for 20 min. After media sterilization, a 
sucrose solution (for CM) or glucose solution (for DM), 
separately autoclaved at 121 °C, was added.
Preparation of spore inoculum
Spores were propagated on CYA plates for 7  days and 
harvested with approximately 5 mL of cold MiliQ water 
containing 0.9% NaCl and 0.01% Tween solution, fol-
lowed by filtration through Miracloth (Merck Millipore), 
centrifuged at 5000 g and the spore pellet washed again 
with 10  mL MiliQ water. Spores were counted using 
a Bürker–Türk counting chamber, followed by inocu-
lation of bioreactors to a final spore concentration of 
1 × 109 spores/L.
Bioreactors
All bioreactor batch cultivations were carried out in Sar-
torious 1  L bioreactors (Satorious Stedim Biotech) with 
a working volume of 0.9 L, equipped with 2 Rushton six-
blade disc turbines. Throughout the cultivation the tem-
perature was maintained at 25  °C and the pH was kept 
constant at 6.5 by automatic addition of 2  M NaOH or 
 H2SO4. The bioreactors were sparged with sterile atmos-
pheric air. For the first 1200 min, the airflow was linearly 
increased from 0.1 volume of air per volume of liquid per 
minute (vvm) to 0.9 vvm and the stirring rate from 100 to 
600 rpm. After that, these parameters were kept constant. 
The off-gas concentrations of oxygen and carbon dioxide 
were measured with a Prima Pro Process Mass Spec-
trometer (Thermo-Fischer Scientific), calibrated monthly 
with gas mixtures containing 5% (v/v)  CO2, 0.04% (v/v) 
ethanol and methanol, 1% (v/v) argon, 5% (v/v) and 15% 
(v/v) oxygen all with nitrogen as carrier gas. The pH elec-
trode (Mettler Toledo) was calibrated according to man-
ufacturer’s standard procedures.
Biomass dry weight determination
Growth rates were determined based on biomass 
dry weight samples collected during the exponen-
tial growth phase. First a known amount of cell culture 
(typically around 3  mL) was filtered through pre-dried 
and weighted 0.45 µm polyether sulfone filters (Sartorius 
Stedim Biotech) which was then washed with deminer-
alized water. The filter was folded to lock the biomass 
inside and dried in a microwave at 150  W for 20  min. 
The dry weight was measured after a cooling period of 
approximately 30 min in a desiccator.
Glucose concentration determination
For quantification of the glucose concentration in the 
culture medium, fermentation broth was filtered through 
a Q-Max® Ca-Plus Filter (Frisenette ApS) with a pore size 
of 0.45 µm and stored at −20 °C until analysis. Separation 
and detection of the compounds was accomplished with 
a high performance liquid chromatography (HPLC) sys-
tem equipped with a Bio-Rad Aminex HPX-87H column 
(BioRad) coupled to a RI detector. Elution was performed 
isocratically with  H2SO4 (5 mM) as the mobile phase with 
a flow velocity of 0.6 mL/min at 60 °C. Quantification was 
performed using a six-level external calibration curve.
Calculations of physiological characteristics
The end of the lag phase was determined as the time 
point were the percentage of  CO2 in the off gas was con-
secutively over 6%.
Maximum specific growth rates were calculated via 
linear regression on a semi-logarithmic scale on at least 
three experimental biomass dry weight data points 
during the exponential phase and all  R2 values were 
at least 0.96. Maximum  CO2 production rates where 
determined similarly but with an  R2 of at least 0.99. A 
custom script was developed in the statistical program-
ming language R to determine the duration of the non-
exponential growth phase for all cultivations, defined 
as the time difference between the end of the exponen-
tial fit to the  CO2 exhaust, and the time point where the 
maximum overall  CO2 production was reached. The 
code is available at: https://github.com/JensChrNielsen/
Fungal-Biol-Biotechnol-2017.
The overall biomass yield on glucose was calculated as 
the ratio between the biomass gain and the glucose con-
sumption in the growth phase.
Secondary metabolite analysis
With the aim of identifying the secondary metabolite 
profiles in the fermentation broth of the ten Penicillium 
species grown in two different media, the filtered broth 
was extracted with ethyl acetate, analyzed with ultra-
high performance liquid chromatography-diode array 
detection-quadrupole time of flight mass spectrometry 
UHPLC–DAD–QTOFMS, and known compounds were 
identified using an in-house compound library.
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Extraction
The fermentation broth was filtered through a 0.45  µm 
cellulose acetate filter (Frisenette), for extraction of non-
polar compounds 1.0  mL of ethyl acetate extraction 
solvent was added to 0.8 mL of filtrate. After ultra-son-
ification for 1 h and centrifugation for 1 min at 13,000g 
the organic (top) layer was transferred to a clean vial. 
For extraction of polar compounds 1.0 mL of acidic ethyl 
acetate (ethyl acetate +  0.5% formic acid) was added to 
the remaining filtrate. Following ultra-sonification and 
centrifugation the organic (top) layer was added to the 
extraction solution containing the extracted non-polar 
compounds. The combined solution was evaporated to 
dryness and re-dissolved in 125 µL HPLC grade metha-
nol. After centrifugation for 5 min at 13,000g the super-
natant was directly used for chemical analysis.
UHPLC–DAD–QTOFMS analysis
Secondary metabolite analysis was achieved by UHPLC–
DAD–QTOFMS on a maXis HD orthogonal acceleration 
quadrupole time-of-flight mass spectrometer (Bruker 
Daltonics) equipped with an electrospray ionization (ESI) 
source and coupled to an Ultimate 3000 UHPLC system 
(Dionex, Thermo Scientific). Separation was achieved 
with a Kinetex 2.6 µm  C18, 100 × 2.1 mm (Phenomenex) 
column maintained at 40  °C with a flow rate of 0.4 mL/
min. A linear gradient system composed of 20  mmol/L 
formic acid in water, and 20 mmol/L formic acid in ace-
tonitrile was used, starting from 10% (v/v) acetonitrile 
and increased to 100% in 10  min, maintaining this rate 
for 3 min before returning to the starting conditions. The 
system was re-equilibrated before subsequent sample 
analysis. MS analysis was performed in  ESI+ with a data 
acquisition rate of 10 scans per second at m/z 100–1000, 
switching between 0 and 20 eV fragmentation energy.
Identification of secondary metabolites
Identification of secondary metabolites was performed 
using aggressive dereplication of the full scan high reso-
lution (HR) MS data, and pseudo MS/MS data from the 
20  eV fragmentation trace, using a search list of com-
pounds based on former taxonomic identification and 
a manual search of major peaks in the internal library. 
This library consists of 1500 compounds of which 95% 
are fungal secondary metabolites [16]. Compounds were 
confirmed by comparison of HRMS, UV/Vis and MS/
HRMS to a reference standard. The number of peaks was 
counted by making a list of compounds (dereplicated and 
unknown ones) based on molecular features in the latest 
time sample in the fermentation, with an absolute area 
higher than 500,000 counts and intensity higher than 
10,000 counts. Subsequently, the presence of these com-
pounds was searched for in all the other samples. The 
total amount was determined by counting all compounds 
that were present in two or three of the triplicate sam-
ples, without using a threshold value.
Results
Physiology
Ten different recently genome sequenced wild type 
Penicillium species were cultivated in 1  L controlled 
bioreactors to evaluate their behaviour in submerged 
cultivations. The species were grown in both a defined 
medium for Penicillium (DM) and in the more industri-
ally relevant medium Czapek Yeast Autolysate (CM). 
During the course of the fermentations the  CO2 off gas 
was continuously measured, while biomass dry weight 
was sampled until  CO2 off gas values started declin-
ing. Additionally, for DM the glucose concentration was 
determined at regular time intervals throughout the fer-
mentations. All cultivations were conducted in biological 
triplicates to evaluate the reproducibility of the experi-
ments. The work revealed that the ten tested Penicillium 
species displayed highly diverse growth characteristics 
and responded differently to the two tested nutritional 
regimes, as evident from the growth curves (Fig. 1).
The initial lag phase, in which minimal changes in the 
 CO2 levels were observed, lasted between 11 and 38  h 
on DM, while it was shorter for all species on CM last-
ing between 10 and 18  h, post inoculation (Table  1). In 
particular, P. flavigenum showed a short lag phase on 
both media where exponential growth was reached after 
14 and 11  h for DM and CM, respectively. Penicillium 
vulpinum showed the longest lag phase in DM and CM 
of 38 and 18 h, respectively. Microscopic examination of 
culture broth from the ten species revealed that the lag 
phase was characterized by germination of spores fol-
lowed by elongation of hyphae. After the lag phase, the 
exponential phase was initiated, where the growth rate 
reached its maximum. Here, the morphology of the ten 
species varied as a function of the species and media. In 
CM, all species initially grew as freely dispersed myce-
lium until the maximum  CO2 off gas was reached, after 
which the formation of pellets typically started. In the 
DM, five of the ten species showed pellet formation rela-
tively early in the fermentation; P. steckii and P. solitum 
showed the formation of small dense pellets, P. vulpi-
num and P. coprophilum showed a mixture of pellets and 
clumps, and P. flavigenum showed a mixture of small 
clumps and dispersed growth. The remaining species and 
all species in CM showed dispersed growth at least until 
the time of maximum  CO2 off gas (Table 1).
The duration of the exponential phase proved to be 
correlated with the observed growth morphology, where 
the exponential growth transitioned into non-exponen-
tial growth at the same time as pellet or clump formation 
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occurred. For seven of the ten species, the non-exponen-
tial growth phase was more than ten h in DM, while this 
was the case for four of ten species in the CM (Fig.  2). 
Only P. flavigenum and P. antarcticum showed exponen-
tial growth and dispersed morphology during the entire 
growth phase in both media (Fig. 2 and Additional file 1). 
In contrast, P. vulpinum showed dispersed growth and 
grew exponentially during the entire growth phase in 
CM, while in DM it had pelleted morphology and grew 
exponentially until 36  h, where after the  CO2 off gas 
Fig. 1 Fermentation profiles of ten Penicillium species cultivated in 1 L bioreactors in DM and CM. All fermentations were performed in biological 
triplicates. The  CO2 exhaust values (%) are shown for all triplicate experiments separately as solid lines (right Y-axis), the dry weight (g/L) values are 
shown as a mean with standard deviations as black circles (left Y-axis) and for the defined medium the glucose concentrations are shown as mean 
with standard deviations as open circles (left Y-axis). Light orange shaded area shows the exponential phase and light grey shaded area shows the 
non-exponential phase. For P. polonicum one of the triplicate experiments showed a different growth curve, for this fermentation only the  CO2 
profile is shown. Triangles are the time points were samples for secondary metabolite analysis were taken. The third sample point in P. decumbens 
was at 120 h and falls therefore outside the figure. For P. steckii in DM the samples for secondary metabolite analysis were taken from a different 
experiment with similar growth characteristics
Page 6 of 12Grijseels et al. Fungal Biol Biotechnol  (2017) 4:8 
values were still increasing, but in a non-exponential 
manner, until after 110 h maximum values of exhausted 
 CO2 off gas were reached.
Maximum specific growth rates (µmax) were calcu-
lated based on dry weight values during the exponential 
growth phase. For several species in DM it proved impos-
sible to determine accurate growth rates based on bio-
mass dry weight due to insufficient samples during the 
short exponential phase. As an alternative method for 
the growth rate, the rates of  CO2 production were deter-
mined, as this is directly proportional to the amount of 
metabolically active biomass present, assuming that the 
yield and specific growth rate remain constant [17]. The 
species showed growth rates between 0.19 and 0.24 h−1 
in DM and between 0.2 and 0.35  h−1 in CM (Fig.  3). 
The biomass yields on glucose during the growth phase 
 (Ysx) varied highly among species; between 0.25 g DW/g 
glucose for P. polonicum to 0.67  g DW/g glucose for 
P. arizonense. The species with the lowest  Ysx values, P. 
polonicum, P. steckii, P. solitum and P. coprophilum (all 
under 0.4  g DW/g glucose) all showed pellet formation 
and/or wall growth, while species with high yields, P. nal-
giovense and P. arizonense (0.6 and 0.67 g DW/g glucose), 
showed dispersed growth.
Secondary metabolite analysis
Samples taken during different stages of the submerged 
cultivations were filtered, extracted, and analyzed for the 
presence of secondary metabolites in the fermentation 
medium using reverse phase UHPLC coupled to time-
of-flight (QTOF) MS. Analysis of the biological triplicate 
experiments for each of the tested species in either of the 
two media were found to be highly reproducible based on 
the occurrence of base peak chromatogram (BPC) peaks 
with the same retention times and comparable peak areas 
in the normalized chromatograms (examples given in 
Fig. 4).
To allow for identification of the individual compounds 
found in the samples, the effluent from the UHPLC col-
umn was directly analysed by the attached QTOFMS 
which allowed for the recording of accurate mass. 
For each sample taken at the end of the cultivation the 
amount of molecular features (equivalent with the num-
ber of different compounds) above an area threshold of 
500,000 and an intensity of 10,000 counts in the UHPLC–
QTOFMS data was determined. The ten different spe-
cies each displayed a unique metabolic profile in the 
two tested media (Table 2 and Additional file 2). A mini-
mum of two compounds was observed in P. flavigenum 
Table 1 Physiological characteristics of ten Penicillium species cultivated in 1 L bioreactors in DM and CM
Biomass yield on glucose (g DW/g glucose), duration of lag phase (h) and observed morphology at the time point where the  CO2 was at its maximum
Species Biomass yield growth phase  (Ysx)
DM (g DW/g glucose)
Lag phase
DM (h)
Morphology
DM
Lag phase
CM (h)
Morphology
CM
P. flavigenum 0.58 ± 0.05 14.3 ± 0.5 Small clumps/dispersed 10.9 ± 0.3 Dispersed
P. nalgiovense 0.60 ± 0.17 22.5 ± 0.8 Dispersed 14.5 ± 0.1 Dispersed
P. coprophilum 0.37 ± 0.03 23.3 ± 0.6 Pellet 12.2 ± 0.6 Dispersed
P. decumbens 0.55 ± 0.02 17.8 ± 0.9 Dispersed 13.8 ± 0.2 Dispersed
P. vulpinum 0.54 ± 0.14 37.6 ± 1.4 Pellet + clumps + wall 18.3 ± 0.2 Dispersed
P. polonicum 0.25 ± 0.01 30.3 ± 1.7 Wall growth 11.3 ± 0.1 Dispersed
P. antarcticum 0.58 ± 0.03 19.7 ± 0.2 Dispersed 12.5 ± 0.1 Dispersed
P. steckii 0.37 ± 0.02 10.9 ± 2.3 Pellet + wall growth 13.5 ± 0.2 Dispersed
P. solitum 0.29 ± 0.13 19.9 ± 1.2 Pellet + wall growth 9.9 ± 0.2 Dispersed
P. arizonense 0.67 ± 0.04 21.4 ± 0.4 Dispersed 14.0 ± 0.8 Dispersed
Fig. 2 Length of non-exponential growth phase of ten Penicillium 
species cultivated in 1 L bioreactors in DM and CM. Non-exponential 
growth phase was the time in hours between the end of exponential 
growth phase and the maximum  CO2 off gas value. Bars show aver-
age and standard deviation if triplicate submerged fermentations. P. 
flavigenum in DM, P. polonicum in CM and P. solitum in CM showed 
exponential growth until the maximum  CO2 off gas value
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cultivated in DM, and a maximum of 34 compounds in P. 
steckii cultivated in CM (last column in Table 2). In eight 
out of the ten species a greater number of compounds 
were detected in the cultivations conducted in CM com-
pared to DM; exceptions were P. polonicum, where cul-
tivation in DM showed a greater number of peaks than 
in CM, and P. solitum, where the number of compounds 
was equal in DM and CM.
Additionally, metabolite profiling was performed to 
identify the known compounds produced during the fer-
mentations. In total 34 different metabolites were iden-
tified, from which most of them could be confirmed by 
comparison of HRMS, UV/Vis and MS/HRMS to a refer-
ence standard. Most compounds were unique to one of 
the ten species, with the exception of chrysogine iden-
tified in three species (P. nalgiovense, P. flavigenum and 
P. antarcticum), fungisporin in three species (P. copro-
philum, P. nalgiovense and P. flavigenum) and andrastin 
A in two species (P. vulpinum and P. decumbens), while 
andrastin C was only identified in P. decumbens. Addi-
tionally, the roquefortine pathway was identified in three 
species (P. coprophilum, P. vulpinum and P. flavigenum), 
where depending on the media and species, different 
intermediates and end products of this pathway could be 
Fig. 3 Maximum specific growth rates and maximum  CO2 production rates for ten Penicillium species cultivated in 1 L bioreactors in DM and CM. 
Dark grey bars: maximum specific growth rates µmax  (h−1) and standard deviations calculated by linear regression of minimum three biomass dry 
weight data points during the exponential phase. For P. vulpinum, P. polonicum, P. steckii, and P. solitum in DM there were less than three dry weight 
samples during exponential phase and therefore µmax could not be calculated. Light grey bars: maximum production rate of  CO2  (h
−1) and standard 
deviations calculated by linear regression of accumulated  CO2 values during exponential growth. All values are based on independent triplicate 
fermentations, except for the ones with an asterix; there the values are based on duplicate fermentations
Fig. 4 Base peak chromatograms (BPCs) of extracted samples of biological triplicates of P. nalgiovense and P. vulpinum fermentations in CM and DM. 
The BPCs of the triplicates are shown in red, dark orange and light orange. BPCs show peaks with the similar retention times and comparable peak 
areas. Peak with asterisk showed a slight change of retention times but have the same molecular features
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identified; in P. flavigenum only meleagrin and precur-
sors were identified while both in P. coprophilum and P. 
vulpinum the end product of the pathway, oxaline was 
identified. Three species–metabolite relationships have, 
to our knowledge, not been described in literature before: 
P. vulpinum and P. decumbens producing andrastin A and 
P. flavigenum producing chrysogine.
To identify in which stages of the fermentation the 
various metabolites were produced, we examined the 
individual metabolite production profiles covering the 
three analyzed stages of the fermentation, one during 
the growth phase, one a few hours after the  CO2 val-
ues started decreasing and one in the stationary phase 
(depicted as triangles in Fig. 1 and exact values in Addi-
tional file 2). This analysis revealed production of specific 
metabolites was associated with specific growth phases of 
the cultivations. For example for P. coprophilum in DM, 
the metabolites from the roquefortine/oxaline pathway 
were already present in the first sample, while griseoful-
vin and dechlorogriseofulvin could only be detected in 
the last sample. Another example of this stage depend-
ing production was P. steckii grown in CM where the vast 
majority of the metabolites were identified at the second 
sample point, while trichodermamide C was only first 
observed at the third sample point. Many of the metabo-
lites in P. steckii were identified as belonging to the family 
of hynapenes and arohynapenes (based on UV and accu-
rate mass) but because of a lack of reference standards 
could not be assigned to specific peaks and are therefore 
not shown in Table  2. In some cases, metabolites were 
produced only in CM or DM; penicillic acid was only 
produced in P. polonicum in CM, calbistrin A was only 
detected in P. decumbens in CM, and atlantinone A was 
only detected in P. solitum in DM. This was also seen for 
unidentified metabolites (Additional file 2). In 17 out of 
the 20 cultivations the metabolite levels in the third sam-
ple were higher than in the second sample, showing that 
part of the metabolites started to be produced only after 
the growth phase.
Discussion
The fungal kingdom contains a huge reservoir of bioac-
tive secondary metabolites; however, the development 
from discovery of a relevant metabolite to application 
remains a challenge. The recent genome sequencing of 
ten secondary metabolite rich Penicillium species facili-
tates exploitation of their genome sequences and/or their 
use as native producing cell factories. The aim of this 
study was to determine the suitability of these ten Peni-
cillia as novel cell factories for native compounds by test-
ing their growth performance and secondary metabolite 
production in submerged cultivations.
Cultivation of the fungal species in controlled sub-
merged bioreactors proved that the ten wild type Peni-
cillium species all could be cultivated using the same 
conditions. The cultivations proved to be highly repro-
ducible, both in defined medium (DM) and rich medium 
(CM). In 18 out of the 20 cultivations, replicate values for 
 CO2 off gas and biomass dry weight concentrations were 
reproducible with maximum  CO2 production rates hav-
ing standard deviations between 1 and 27%. The cultiva-
tions performed in CM showed dispersed growth until 
the maximum  CO2 off gas was reached, while five out of 
the ten species cultivated in DM showed clump/pelleted 
growth. The fungal morphology can have an enormous 
impact on the production of enzymes and primary or 
secondary metabolites [18]. For example, micro-colonies 
are required for the production of citric acid by A. niger 
[19]. However, there is not a defined formula on how 
morphology affects productivity and it should be tested 
and optimized for the relevant species and metabolites. 
The work conducted in this study can be used as a start-
ing point in optimization of process parameters for the 
production of a specific secondary metabolite.
Maximum specific growth rates in DM were calcu-
lated to be between 0.14 and 0.22 h−1 depending on the 
species, and in CM between 0.17 and 0.29  h−1. In case 
of pellet formation the cultures grew only exponentially 
in the beginning of the cultivation prior to pellet forma-
tion. The obtained growth rates are reasonable start-
ing points for industrial fermentations, for example the 
penicillin producing P. chrysogenum, has a maximum 
growth rate under comparable conditions of around 
0.2  h−1 [20, 21]. An interesting observation is that the 
species with the highest growth rates, P. decumbens 
and P. coprophilum, have the smallest genome size [15]. 
The biomass yields during the growth phase on glucose 
varied highly between species and there was a correla-
tion between yields and morphology: species with low 
yields all showed pellet formation and/or wall growth, 
while species with high yields showed dispersed growth. 
In case of wall growth, this can be explained by the bio-
mass determination method used in this study: broth was 
sampled from a port in the reactor, which in the case of 
wall growth resulted in a lower biomass value than the 
real biomass value in the reactor, and a lower yield. One 
hypothesis for the low yields observed in pelleted growth 
cultures is that dense hyphal packing may often result in 
diffusional limitation of both nutrients and oxygen, which 
can cause autolysis of the pellet core [22]. This can lead to 
a decrease of dry cell mass, as was previously observed 
in cultures of P. chrysogenum where hyphal elements 
showed cell wall degradation and clear signs of autolysis, 
even during the culture growth phase [23].
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Similar to the growth profiles, the UHPLC–QTOFMS 
metabolite profiles showed to be reproducible in the bio-
logical triplicates of the batch fermentations. The base 
peak chromatograms revealed that all ten species pro-
duced secondary metabolites in submerged cultivations, 
with most of the metabolites being unique to one of the 
ten species. The media composition had an influence on 
secondary metabolite profiles, with eight out of ten spe-
cies producing a higher number of compounds in CM 
than in DM. This is not surprising as the yeast extract 
containing CYA medium is regarded as a secondary 
metabolite inducing medium [24]. Some species such as 
P. solitum and P. flavigenum produced very few metabo-
lites in both media; these species could be interesting for 
the development of secondary metabolite free produc-
tion hosts, especially P. flavigenum since it showed to 
have a high reproducibility and a high growth rate. It has 
been shown in both P. chrysogenum [25] and in Strepto-
myces species [26, 27] that removal of highly producing 
secondary metabolite pathways can increase the produc-
tion of other native, or heterologous secondary metabo-
lites. However, the species producing very few secondary 
metabolites still contain many secondary metabolite bio-
synthetic gene clusters (BGCs). In a recent large scale 
genomic analysis of Penicillium genomes, it was found 
that 24 Penicillium genomes (including the ten used in 
this study) contained in total 1317 putative BGCs, cor-
responding to an average of 55 clusters per species [15]. 
This means that a great number of BGCs were inactive in 
the conditions used in this study, especially when taken 
into account that one BGC is often responsible for the 
biosynthesis of a whole family of related metabolites.
Dereplication of the extracts showed that the species 
produced a broad spectrum of secondary metabolites 
belonging to several different metabolite classes (polyke-
tides, non-ribosomal peptides and terpenes). In total we 
identified 34 different known compounds, of which many 
for the first time in submerged fermentations. Here, it 
has to be taken into account that because of the chemi-
cal diversity of the secondary metabolites the extraction 
could not be optimal for all compounds, and it was only 
possible to obtain semi-quantitative data. Several of the 
identified compounds are known to have antibacterial, 
antifungal and anti-cancer activities, such as the antifun-
gal griseofulvin, the antibiotic roquefortines [28] as well 
as the promising anti-cancer metabolites andrastin A 
[29, 30] and calbistrin A [31]. At the same time also sev-
eral mycotoxins such as patulin and penicillic acid were 
produced of which elimination need to be considered in 
a production process. Additionally, we described three 
new species–metabolite relationships: to our knowledge, 
this is the first time that P. decumbens and P. vulpinum 
are described as andrastin A producers and P. flavigenum 
as chrysogine producer. Furthermore, it was shown that 
the species produce many unknown compounds at lev-
els above the used detection area threshold; these could 
be interesting targets for isolation, bioactivity testing and 
structural elucidation, especially because it is less labori-
ous to isolate metabolites from submerged cultures than 
from agar plates.
In order to utilize metabolic reprogramming tech-
niques to optimize production of a secondary metabo-
lite, the corresponding BGC of the metabolite must first 
be identified. The BGCs responsible for production of 
the detected andrastin A, patulin, griseofulvin, pseuro-
tin A, fungisporin and roquefortine/meleagrin pathways 
have all previously been identified and characterized 
[32–42]. Although the experimental characterization 
was done in different species, represents for each of the 
listed BGCs, except for andrastin A, were recently iden-
tified in at least one of the ten analyzed species used in 
this study [15]. Several other metabolites with predicted 
BGCs and previously detected in solid cultivations of 
the corresponding strains, could not be detected in the 
submerged cultivations of the same strain. This was the 
case for yanuthones previously detected in extracts of 
P. flavigenum grown on agar plates [15], and fumagillin, 
pyripyropenes, austalides, and tryptoquivalines, previ-
ously detected in extracts of P. arizonense grown on agar 
plates [14]. In this context it is interesting that a species 
like P. arizonense only secreted pseurotin A, despite the 
large potential for producing a vast number of second-
ary metabolites. This would be an advantage if pseurotin 
A has to be produced in an industrial fermentation, but 
a disadvantage if any of its other secondary metabolites 
should be produced [14]. Furthermore we detected small 
amounts of penicillin G in the CM extracts of the known 
penicillin G producer P. nalgiovense, but the intensity and 
area were lower than the threshold values used in this 
study. It should be considered that in the experiments 
conducted in this study the biomass was filtered out and 
only the secreted metabolites were studied, while in plate 
experiments the intracellular metabolites are also taken 
into account.
Conclusions
The results of this study show that the fermentation 
properties of the ten analysed Penicillium species and the 
highly reproducible performance in bioreactors should 
be considered as very encouraging for the application 
of native hosts for production via submerged fermenta-
tion. The Penicillium species (isolates) showed promis-
ing growth characteristics for use in large-scale industrial 
bioprocesses and produced a diverse range of interesting 
secondary metabolites. The production of specific sec-
ondary metabolites can subsequently be optimized by 
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process optimization, classical strain development and/
or with metabolic engineering approaches. Furthermore, 
all ten species used in this study were recently genome 
sequenced, which makes the use of rational approaches 
for improving the product yields or eliminating the pro-
duction of other compounds more accessible thanks 
to the ongoing development of CRISPR/Cas9 genome 
editing techniques, which has recently been successfully 
demonstrated in filamentous fungi [43, 44]. The work 
conducted in this study can assist in deciding the opti-
mization strategy for specific secondary metabolites pro-
duced by one of the ten Penicillium species.
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